Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP610725.RAF4DXJfj783cvAulo35vt0Qznn9tSQem1QcLpyLuVYWg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP610725.RAF4DXJfj783cvAulo35vt0Qznn9tSQem1QcLpyLuVYWg130_assertion type Assertion NP610725.RAF4DXJfj783cvAulo35vt0Qznn9tSQem1QcLpyLuVYWg130_head.
- NP610725.RAF4DXJfj783cvAulo35vt0Qznn9tSQem1QcLpyLuVYWg130_assertion wasGeneratedBy ECO_0000203 NP610725.RAF4DXJfj783cvAulo35vt0Qznn9tSQem1QcLpyLuVYWg130_provenance.
- NP610725.RAF4DXJfj783cvAulo35vt0Qznn9tSQem1QcLpyLuVYWg130_assertion wasDerivedFrom befree-2016 NP610725.RAF4DXJfj783cvAulo35vt0Qznn9tSQem1QcLpyLuVYWg130_provenance.
- NP610725.RAF4DXJfj783cvAulo35vt0Qznn9tSQem1QcLpyLuVYWg130_assertion SIO_000772 17511025 NP610725.RAF4DXJfj783cvAulo35vt0Qznn9tSQem1QcLpyLuVYWg130_provenance.
- NP610725.RAF4DXJfj783cvAulo35vt0Qznn9tSQem1QcLpyLuVYWg130_assertion evidence source_evidence_literature NP610725.RAF4DXJfj783cvAulo35vt0Qznn9tSQem1QcLpyLuVYWg130_provenance.
- NP610725.RAF4DXJfj783cvAulo35vt0Qznn9tSQem1QcLpyLuVYWg130_assertion description "[To investigate the relationship between cycloo-xygenase-2 (COX-2), and vascular endothelial growth factor (VEGF), and to determine the clinical significance of this relationship in esophageal cancer patients undergoing chemoradiotherapy (CRT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610725.RAF4DXJfj783cvAulo35vt0Qznn9tSQem1QcLpyLuVYWg130_provenance.